Article
Dissimilar Trypanosoma cruzi genotype-specific serological profile assessed by Chagas-Flow ATE IgG1 upon benznidazole etiological treatment of chronic Chagas disease.
PLoS neglected tropical diseases - 1 Sept 2024
Alessio Glaucia Diniz, Silvestrini Carolina Malheiros Araújo, Elói-Santos Silvana Maria, Gontijo Eliane Dias, Sales Júnior Policarpo Ademar, Vitelli-Avelar Danielle Marchetti, Sathler-Avelar Renato, Wendling Ana Paula Barbosa, Teixeira-Carvalho Andréa, de Lana Marta, Martins-Filho Olindo Assis
Abstract excerpt
The present study aimed to verify the impact of etiological treatment on the genotype-specific serological diagnosis of chronic Chagas disease patients (CH), using the Chagas-Flow ATE IgG1 methodology. For this purpose, a total of 92 serum samples from CH, categorized as Not Treated (NT, n = 32) and Benznidazole-Treated (Bz-T, n = 60), were tested at Study Baseline and 5Years Follow-up. At Study Baseline, all...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
